Abiopharma

🔍 Green Emily Nagle (Director)

Company: CENTERSPACE (CSR)

Report Date: 2026-06-01

Detailed Transactions and Holdings:

• Acquired 1,446 shares of Common Shares of Beneficial Interest (Direct)
  Date: 2026-06-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,568.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Shares of Beneficial Interest (Direct)
  Date: 2026-06-01 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 454.20
• Sold 1,446 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-01 | Code: M | Expires: 2026-06-01 | Exercise: 2026-06-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one common share of beneficial interest of Centerspace.
• F2: Includes 16.00 shares to the total shareholding which were acquired under the Company's dividend reinvestment program.